FactSet Research (FDS) Q1 Earnings and Revenues Top Estimates

FactSet reported adjusted quarterly EPS of $4.51 versus the Zacks consensus of $4.39 (a +2.73% surprise) and revenue of $607.62 million for the quarter ended November 2025, topping estimates by 1.36% (year-ago revenue was $568.67m). The company has beaten EPS estimates two of the last four quarters and carries a Zacks Rank #3 (Hold); consensus for the next quarter is $4.32 on $601.7m and $17.31 on $2.44bn for the fiscal year. Shares have underperformed this year (down ~38.3% YTD vs S&P +14.3%), and management commentary on the earnings call and subsequent estimate revisions will be the key driver of near-term stock movement.

Analysis

Market structure: FactSet's beat is modest (EPS +2.7%, revs +1.4%) but the stock is down ~38% YTD, signaling multiple compression rather than a one-quarter operational shock. Winners: deep-pocketed competitors (S&P Global, LSEG) and market infrastructure (NDAQ, ICE) that can undercut pricing or cross-sell bundled data; losers: smaller data vendors and vendors reliant on asset-management budgets if AUM/trading activity falls. The immediate pricing power remains intact due to sticky subscription revenue, but secular demand for cheaper API/data feeds is increasing and will pressure incremental pricing over 12–24 months.

Risk assessment: Key tail risks are a large client churn event (loss of ≥1% revenue client), regulatory pricing caps/data unbundling in Europe/US, or a material data breach — any of which could knock 8–20% off consensus FY EPS. Short-term (days–weeks) sensitivity centers on management commentary and Q guidance revisions; medium-term (3–12 months) depends on estimate revisions and client pipeline; long-term (12+ months) hinges on product innovation and M&A activity. Hidden dependencies include AUM-linked demand and FX exposure; a 5% drop in global equity AUM could translate to a ~1–2% revenue hit.

Trade implications: For tactical exposure take a conditioned long: size modestly (2–3% portfolio) with disciplined stops and hedge with index or option protection; expect a 12-month recovery if FY EPS holds ≥$17 and revenue guidance is within ±1% of consensus. Use a 3-month put spread (sell ~10% OTM, buy ~20% OTM) to collect premium while capping downside, or a 6-month call spread (buy ATM, sell +25% OTM) to express asymmetric upside. Rotate modestly into market infrastructure (NDAQ) as defensive exposure and avoid/short highly cyclical names like BBCP until revenue stabilizes.

Contrarian angles: The market may have over-rotated on sentiment — a beaten-down multiple could re-expand if management announces buybacks/M&A or better client renewal metrics; historically, data vendors have re-rated 20–40% on credible product-led growth or margin expansion. Conversely, if guidance misses by >3% or consensus cuts >5% in next 30 days, downside is likely already partially priced but could extend another 15–25%. Watch for activist interest as a catalyst — a realistic trigger for re-rating within 3–9 months.

Key Decisions for Investors

• Establish a 2–3% long position in FDS (FactSet) for a 9–12 month horizon if post-call guidance keeps FY EPS ≥ $17 and next-quarter revenue guidance is within ±1% of consensus; target +25–35% upside, set a hard stop-loss at −15%.
• Implement a protective/options income trade: sell a 3-month put spread on FDS (sell ~10% OTM put, buy ~20% OTM put) sized to 1–1.5% of portfolio to collect premium while capping assignment risk; unwind if premium <1% of notional or if guidance misses by >3%.
• Hedge market beta: when initiating the FDS long, short SPY exposure equal to ~60% of FDS dollar exposure (beta hedge) to isolate stock-specific recovery; unwind hedge if FDS outperforms SPY by +10% or after 3–6 months.
• Avoid/initiate a small tactical short (≤0.5% portfolio) in BBCP ahead of its report; short only if revenues miss consensus (>5% miss) or if consensus EPS is unchanged and management commentary is weak — place a 10% stop-loss on the short.